Skip links
Skip to content
Contact Us
Search
Search
Who We Serve
Patients
Providers
Biopharma
Payors
Therapeutic Areas
Allergy & Immunology
Cardiology
Cell & Gene Therapy
Genetics
Neurology
Pulmonology
View All
Therapies
Solutions
Specialty Pharmacy
Patient Services Hub
Third-Party Logistics
Home Infusion & Nursing
About
Our Story
Leadership
Patient Stories
Resources
Accreditations
Careers
Send a Prescription
Contact Us
Prescribe a Therapy
Orsini is the exclusive specialty pharmacy provider for MIPLYFFA™ (arimoclomol), the first FDA-approved treatment for Niemann-Pick disease type C.
Learn more →
Toggle navigation
Who We Serve
Patients
Providers
Biopharma
Payors
Therapeutic Areas
Allergy & Immunology
Cardiology
Cell & Gene Therapy
Genetics
Neurology
Pulmonology
View All
Therapies
Solutions
Specialty Pharmacy
Patient Services Hub
Third-Party Logistics
Home Infusion & Nursing
About
Our Story
Leadership
Patient Stories
Resources
Accreditations
Careers
Send a Prescription
Contact Us
Niemann-Pick disease type C (NPC)
MIPLYFFA™ (arimoclomol)
Miglustat
Yargesa™ (miglustat)
Adding {{itemName}} to cart
Added {{itemName}} to cart
Loading...
×
